Literature DB >> 3144408

Prolonged hypogonadism in male patients with rheumatoid arthritis during flares in disease activity.

D Gordon1, G H Beastall, J A Thomson, R D Sturrock.   

Abstract

The pituitary-gonadal axis was assessed in 10 male patients during hospital admissions lasting 3-6 weeks (median 3 weeks) for flares for rheumatoid arthritis. Despite significant improvements in the Ritchie indices from median 16 (range 9-23) to 8.5 (range 5-20) (p less than 0.01) and ESR from median 67 mm/h (range 46-115 mm/h) to 58 mm/h (range 15-116 mm/h) (p less than 0.05) there were no significant changes in serum testosterone, LH, FSH, prolactin (PRL), cortisol or androstenedione during the admission periods. At follow-up (median 14 months, range 5-18 months after admission) there were further improvements in articular indices (median 7, range 3-13; p = NS) and ESR (median 20 mm/h, range 4-62 mm/h; p less than 0.05) and rheumatoid factor titres had fallen from median 1/1025 (range 1/126 to 1/1024) to median 1/512 (range 1/64 - 1/512). One patient showed biochemical features of progressive testicular failure. In the remaining patients, serum and derived free testosterone levels were significantly increased (p less than 0.01 respectively) and serum LH reduced (p less than 0.01). There were no changes, at this time, in prolactin, cortisol or androstenedione. Rheumatoid flares appear to be associated with prolonged suppression of testicular function.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3144408     DOI: 10.1093/rheumatology/27.6.440

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  15 in total

Review 1.  Cellular and molecular perspectives in rheumatoid arthritis.

Authors:  Douglas J Veale; Carl Orr; Ursula Fearon
Journal:  Semin Immunopathol       Date:  2017-05-15       Impact factor: 9.623

2.  A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity.

Authors:  L Mirone; L Altomonte; P D'Agostino; A Zoli; A Barini; M Magaro
Journal:  Clin Rheumatol       Date:  1996-01       Impact factor: 2.980

3.  Decreased plasma gonadotropin and testosterone levels in arthritic rats: are corticosteroids involved?

Authors:  C Rivier
Journal:  Endocrine       Date:  1995-05       Impact factor: 3.633

Review 4.  Autoimmune diseases and reproductive aging.

Authors:  Riley Bove
Journal:  Clin Immunol       Date:  2013-02-28       Impact factor: 3.969

5.  Serum androgen-anabolic hormones and the risk of rheumatoid arthritis.

Authors:  R Heikkilä; K Aho; M Heliövaara; P Knekt; A Reunanen; A Aromaa; A Leino; T Palosuo
Journal:  Ann Rheum Dis       Date:  1998-05       Impact factor: 19.103

Review 6.  Klinefelter's syndrome and rheumatoid arthritis. Report of a case and review of the literature.

Authors:  S Kobayashi; S Yamamoto; M Tanaka; H Hashimoto; S Hirose
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

7.  Methotrexate treatment ameliorated testicular suppression and anorexia related leptin reduction in rats with adjuvant arthritis.

Authors:  Jana Jurcovicova; Karol Svik; Sona Scsukova; Katarina Bauerova; Jozef Rovensky; Maria Stancikova
Journal:  Rheumatol Int       Date:  2009-01-21       Impact factor: 2.631

8.  Lack of association between CAG repeat polymorphism in the androgen receptor gene and the outcome of rheumatoid arthritis treatment with leflunomide.

Authors:  Violetta Dziedziejko; Mateusz Kurzawski; Krzysztof Safranow; Andrzej Ossowski; Jaroslaw Piatek; Miroslaw Parafiniuk; Dariusz Chlubek; Andrzej Pawlik
Journal:  Eur J Clin Pharmacol       Date:  2011-10-14       Impact factor: 2.953

Review 9.  Androgens in rheumatoid arthritis: when are they effectors?

Authors:  Maurizio Cutolo
Journal:  Arthritis Res Ther       Date:  2009-09-22       Impact factor: 5.156

10.  A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis.

Authors:  Elizabeth W Karlson; Lori B Chibnik; Monica McGrath; Shun-Chiao Chang; Brendan T Keenan; Karen H Costenbader; Patricia A Fraser; Shelley Tworoger; Susan E Hankinson; I-Min Lee; Julie Buring; Immaculata De Vivo
Journal:  Arthritis Res Ther       Date:  2009-06-25       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.